Evidence map›Paper›PMID 33983979›Full record

ArticlePloS one2021

Predictive factors of venous recanalization in upper-extremity vein thrombosis.

Gaëtan Ploton, Nicolas Brebion, Béatrice Guyomarch, Marc-Antoine Pistorius, Jérôme Connault, Jeanne Hersant, Alizée Raimbeau, Guillaume Bergère, Mathieu Artifoni, Cécile Durant and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Gaëtan PlotonDepartment of Internal Medicine and Vascular Medicine, CHU de Nantes, Nantes, France.
Nicolas BrebionDepartment of Vascular Medicine, CHD La Roche-sur-Yon, La Roche-sur-Yon, France.
Béatrice GuyomarchDirection de la recherche, Plateforme de Méthodologie et Biostatistique, CHU de Nantes, Nantes, France.
Marc-Antoine PistoriusDepartment of Internal Medicine and Vascular Medicine, CHU de Nantes, Nantes, France.
Jérôme ConnaultDepartment of Internal Medicine and Vascular Medicine, CHU de Nantes, Nantes, France.
Jeanne HersantDepartment of Internal Medicine and Vascular Medicine, CHU de Nantes, Nantes, France.
Alizée RaimbeauDepartment of Internal Medicine and Vascular Medicine, CHU de Nantes, Nantes, France.
Guillaume BergèreDepartment of Internal Medicine and Vascular Medicine, CHU de Nantes, Nantes, France.
Mathieu ArtifoniDepartment of Internal Medicine and Vascular Medicine, CHU de Nantes, Nantes, France.
Cécile DurantDepartment of Internal Medicine and Vascular Medicine, CHU de Nantes, Nantes, France.
Giovanni GautierDepartment of Internal Medicine and Vascular Medicine, CHU de Nantes, Nantes, France.
Romain DumontUNAV, Nantes Vascular Access Unit, CHU de Nantes, Nantes, France.
Jean-Manuel KubinaDepartment of Vascular Medicine, CHD La Roche-sur-Yon, La Roche-sur-Yon, France.
Claire ToquetDepartment of Pathology, CHU de Nantes, Nantes, France.
Olivier EspitiaDepartment of Internal Medicine and Vascular Medicine, CHU de Nantes, Nantes, France.ORCID 0000-0003-0821-9990
Centre Hospitalier Universitaire de Nantes · FRRoche (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUpper extremity venous thrombosis (UEVT) represents about 10% of venous thrombo-embolic disease. This is mainly explained by the increasing use of central venous line, for oncologic or nutritional care. The factors associated with venous recanalization are not known.

objectiveThe aim of this study was to investigate prognosis factor associated with venous recanalization after UEVT.

methodsThis study included patients with UEVT diagnosed with duplex ultra-sonography (DUS) from January 2015 to December 2017 with DUS evaluations during follow-up. A multivariate Cox proportional-hazards-model analysis was performed to identify predictive factors of UEVT complete recanalization.

resultsThis study included 494 UEVT, 304 proximal UEVT and 190 distal UEVT. The median age was 58 years, 39.5% were women. Clinical context was: hematological malignancy (40.7%), solid cancer (14.2%), infectious or inflammatory context (49.9%) and presence of venous catheters or pacemaker leads in 86.4%. The rate of recanalization without sequelae of UEVT was 38%. For all UEVT, in multivariate analysis, factors associated with complete vein recanalization were: thrombosis associated with central venous catheter (CVC) (HR:2.40, [1.45;3.95], p<0.001), UEVT limited to a venous segment (HR:1.94, [1.26;3.00], p = 0.003), occlusive thrombosis (HR:0.48 [0.34;0.67], p<0.0001), the presence of a PICC Line (HR:2.29, [1.48;3.52], p<0.001), a thrombosis of deep and distal topography (HR:1.70, [1.10;2.63], p = 0.02) or superficial thrombosis of the forearm (HR:2.79, [1.52;5.12], p<0.001). For deep and proximal UEVT, non-occlusive UEVT (HR:2.23, [1.49;3.33], p<0.0001), thrombosis associated with CVC (HR:1.58, [1.01;2.47], p = 0.04) and infectious or inflammatory context (HR:1.63, [1.10;2.41], p = 0.01) were factors associated with complete vein recanalization.

conclusionIn this study, factors associated with UEVT recanalization were UEVT limited to a venous segment, thrombosis associated with CVC, a thrombosis of deep and distal thrombosis topography and superficial thrombosis of the forearm. Occlusive thrombosis was associated with the absence of UEVT recanalization.

Indexed as

AdultAgedCatheterization, Central VenousCatheterization, PeripheralCatheters, IndwellingCentral Venous CathetersFemaleFranceHumansLogistic ModelsMaleMiddle AgedOdds RatioPrognosisProportional Hazards ModelsRetrospective Studies

Identifiers

PMID33983979
PMCPMC8118536
OpenAlexW3162446921

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.